Alumni Ventures

Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.

Rob Adams

Executive Partner

Gail Ball

Venture Scout

Andrew Baum

Vice President, Treasury and Capital Management

Helen Chen

CEO Services Analyst

Michael Collins

CEO

Michael Egziabher

Principal, Basecamp

Mason Hale

Senior Associate, Chestnut Street and Triphammer

Madden, Michael J.

Managing Partner and Co-Founder

Todd McIntyre

Managing Partner, Spike Ventures | Alumni Ventures

Jonathan Meltzer

Managing Partner

David Muson

CFO

Michael Peri

Partner

Ludwig Pierre Schulze

Managing Partner and NYC Office Leader

Saad Shaheen

Director

David Shapiro

Managing Partner, Blue Ivy

Chris Sklarin

Managing Partner, Castor Ventures and Strawberry Creek Ventures

Brittney Wade

Senior Associate, Seed Fund and Doctors Innovate Fund

Drew Wandzilak

Senior Associate, Green D and Yard and Strategic Tech Fund

Sarah Worden

Venture Scout

Ray Wu

Managing Partner-Web3 / Blockchain Fund

Michael Yuann

Director of Investment Operations

Matthew Caspari

Managing Partner, Strawberry Creek and amp; Deep Tech

Ron Levin

Managing Partner, AV Seed Fund and Doctors Innovate Fund

Past deals in Healthcare

Springbok Analytics

Series A in 2025
Springbok Analytics offers an AI-powered software platform that transforms MRIs into three-dimensional analyses of muscle to enable true precision. Springbok Analytics' advanced imaging technology identifies and measures each individual muscle, providing data to scientists, physical therapists, athletic trainers, and physicians to evaluate muscle function in relation to performance and injury management. The technology has numerous applications, including injury management, performance enhancement, and the treatment of musculoskeletal conditions.

Torch Dental

Venture Round in 2025
Torch Dental offers an all-in-one technology platform that addresses the supply ordering and inventory management needs of dental practices. By digitizing and optimizing traditional manual processes, Torch Dental simplifies the ordering experience for dental professionals. This allows dentists to dedicate more time to patient care rather than administrative tasks. The company's focus is on enhancing operational efficiency within dental practices, ultimately benefiting both practitioners and their patients.

Lōvu Health

Pre Seed Round in 2024
Lōvu Health is a digital maternal health platform that offers services to care for mother and baby from conception to postpartum.

Andromeda Surgical

Seed Round in 2024
Andromeda Surgical is a developer of autonomous robots designed to enhance the consistency, accuracy, and efficiency of surgical procedures. The company's open platform focuses on urologic procedures that have demonstrated superior outcomes but face challenges in widespread adoption due to technical complexities. By addressing these difficulties, Andromeda Surgical aims to empower surgeons to perform various procedures at a level typically achieved only by experts, thereby improving patient care and surgical success rates.

Beam

Venture Round in 2024
Beam Technologies Inc. is a dental benefits company based in Columbus, Ohio, founded in 2012. It specializes in providing digital-first dental insurance plans that emphasize preventive care and ease-of-use. Beam’s offerings include dental insurance, which features perks such as floss, toothpaste, and the Beam Brush—a wirelessly connected toothbrush that allows users to track and monitor their brushing habits through a smartphone app. The company incorporates rewards for maintaining good dental hygiene into its policy pricing, making it a unique player in the dental benefits market.

AminoChain

Seed Round in 2024
AminoChain operates a blockchain-based platform that enhances the management of biosamples by connecting data from healthcare companies. The platform allows users to oversee bio-sample inventories while ensuring ownership of their assets. It facilitates collaboration among stakeholders through an integrated solution that encompasses sample procurement, agreements, and payments. Additionally, AminoChain focuses on tokenizing and incentivizing stem cell donations, providing donors with compensation for their contributions and offering biobanks a secure method for inventory management.

GC Therapeutics

Series A in 2024
GC Therapeutics specializes in synthetic biology to efficiently program patient-derived stem cells into various cell types. The company has developed a proprietary platform that integrates synthetic biology and artificial intelligence, enabling streamlined manufacturing and improved quality of cell therapies. Their approach allows for the rapid differentiation of pluripotent stem cells, creating unique SuperCells™ customized for specific medical conditions. The foundational technology was developed in Professor George Church's lab at Harvard Medical School, and the team at GC Therapeutics comprises dedicated biologists and tissue engineers focused on translating this innovative method into practical therapies for patients.

Kindbridge Behavioral Health

Pre Seed Round in 2024
Kindbridge Behavioral Health provides individual therapy, family therapy, group services, pricing, and insurance services. They provide treatments for depression, anxiety, gaming, stress, relationships, PTSD, family conflicts, mood disorders, gambling, trauma, addiction, dissociative disorders, and ADHD.

Clarium

Venture Round in 2024
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.

MD Ally

Series A in 2024
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.

Hopscotch Primary Care

Series C in 2024
Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.

Shape

Seed Round in 2024
ShapeScale is a personal 3D scanner that digitizes and measures your body in photorealistic 3D. Leveraging computer vision and deep learning ShapeScale measures changes in body composition your eyes and conventional scales do not see. With fast, visual, and gamified feedback, ShapeScale changes how people keep healthy and stay motivated.

ParcelBio

Seed Round in 2024
ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body.

Nectero Medical

Series D in 2024
Nectero Medical is a clinical-stage biotechnology company based in Dover, Delaware, that focuses on treating mid-sized abdominal aortic aneurysms. Founded in 2017, the company has developed an innovative treatment designed to stabilize the growth of aneurysms and prevent their rupture. This treatment delivers a compound containing a stabilizer agent directly to the aneurysm site, which helps inhibit further breakdown and strengthens the vessel wall. By providing a safer intervention option, Nectero Medical aims to enable patients to receive timely care, significantly delaying or preventing the need for major endovascular or surgical repair.

Torch Dental

Venture Round in 2024
Torch Dental offers an all-in-one technology platform that addresses the supply ordering and inventory management needs of dental practices. By digitizing and optimizing traditional manual processes, Torch Dental simplifies the ordering experience for dental professionals. This allows dentists to dedicate more time to patient care rather than administrative tasks. The company's focus is on enhancing operational efficiency within dental practices, ultimately benefiting both practitioners and their patients.

Nest Health

Seed Round in 2024
Nest Health is a family healthcare platform that provides a range of medical services aimed at reducing the stress associated with traditional healthcare arrangements. The company specializes in delivering in-home and virtual visits for patients of all ages, including newborns, children, teens, and adults. Their offerings encompass preventive care, sick visits, behavioral health support, nutrition guidance, and chronic disease management. By enabling patients to receive care in the comfort of their homes, Nest Health seeks to enhance accessibility and convenience in healthcare delivery.

BE Therapeutics

Seed Round in 2024
BE Therapeutics is a Biotechnology Research firm offering regenerative medicine therapies and tissue replacement.

Alvee

Seed Round in 2024
Alvee is a developer of an artificial intelligence-driven tool designed to enhance health equity and improve health outcomes for patients. The tool offers real-time, patient-specific alerts that notify healthcare providers and payers when a patient has a confirmed or potential health equity issue. By integrating social determinants of health, chronic conditions, demographic information, and health inequity risks, Alvee provides a comprehensive view of a patient's health equity status. This enables healthcare providers and payers to meet data stratification quality reporting requirements effectively.

Piction Health

Seed Round in 2024
Piction Health is a dermatology care service that provides patients with rapid access to expert dermatological consultations for skin, hair, or nail concerns. Through its application, the company facilitates a streamlined process where patients receive a diagnosis and personalized care plan within two days. Piction Health employs artificial intelligence to enhance the experience for both patients and healthcare providers, enabling primary care physicians to obtain quick second opinions on complex skin conditions. This approach not only improves patient outcomes but also reduces unnecessary repeat visits and ineffective treatments, ultimately accelerating access to high-quality dermatology care from the comfort of home.

Arise

Seed Round in 2024
Arise is a provider of virtual care services focused on supporting individuals with eating disorders, a condition that affects a diverse range of people, yet often goes untreated. The company seeks to address the barriers and stigma associated with these disorders by expanding access to inclusive care through its innovative platform. This platform offers virtual therapy sessions with licensed therapists and dietitians, as well as support from care advocates who assist users in managing daily challenges. By fostering a community and providing ongoing support, Arise aims to deliver a new approach to healing that prioritizes both physical and mental health for those struggling with eating disorders.

Earli

Series A in 2024
Earli is a company focused on developing innovative cancer treatment devices that utilize synthetic biomarkers for early cancer detection. The company's approach involves a novel gene therapy technique known as Synthetic Biopsy, which prompts cancer cells to produce synthetic, non-human biomarkers. These biomarkers can be detected through various means, including blood, urine, or breath, allowing for timely tracking and treatment of cancer. By facilitating the early identification of cancer when it is still homogeneous, Earli aims to significantly enhance survival rates. Their technology not only aids in detection but is also applicable for therapeutic interventions, thereby personalizing treatment and improving patient outcomes.

Featureform

Seed Round in 2023
Featureform develops machine learning tools specifically for pharmaceutical and biotechnology companies. The company offers an open-source virtual feature store that enables data scientists to define, manage, and serve machine learning features throughout their organizations. Its platform provides a unified interface to connect, transform, and join both streaming and batch data. Featureform facilitates the discovery and integration of features created by various teams, allowing them to share and enhance their models. Additionally, the platform includes capabilities to monitor and analyze features, as well as to freeze them, which allows teams to concentrate on building models to support their data pipelines effectively.

Radix Health

Pre Seed Round in 2023
Radix Health is a platform that integrates the healthcare industry with market-based pricing, utilizing software and data engineering.

Clarium

Seed Round in 2023
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.

Jona

Seed Round in 2023
Jona is a technology startup focused on leveraging artificial intelligence to explore the relationship between the microbiome and overall health. The company has developed an advanced microbiome profiling platform that utilizes deep metagenomics technology to analyze a wide range of microorganisms, including bacteria, fungi, viruses, and protists. This analysis creates a comprehensive map that links these microorganisms to various health conditions, symptoms, and food sensitivities. By interpreting microbiome test results, Jona aims to empower individuals to proactively manage their health through informed recommendations on diet, exercise, sleep, and other treatments, addressing the growing prevalence of chronic illnesses.

Ellipsis Health

Series A in 2023
Ellipsis Health, Inc. is a technology company based in San Francisco, California, founded in 2013. It specializes in developing analytics solutions that utilize artificial intelligence to enhance behavioral health assessments by analyzing patient speech and clinical data. The company's platform offers a behavioral biomarker technology that generates clinical-grade evaluations of anxiety and depression severity, as well as sub-clinical assessments of stress. This innovative approach allows healthcare systems to continuously monitor their patient populations for mental health conditions, particularly depression, and facilitates timely support for patients in need. By integrating affective computing into patient and care team interactions, Ellipsis Health aims to create real-time behavioral health vital signs for improved patient outcomes.

Eigen Therapeutics

Seed Round in 2023
Eigen Therapeutics is a biotechnology company on a mission to make therapies that make cancer easier to find and eliminate. Eigen is focused on the development of “priming” therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthy cells more resilient to treatment. Eigen is building a high-throughput discovery platform to explore the space of priming therapies, leveraging proprietary machine learning algorithms to discover novel associations, new classes of drugs, and new potential therapies that change a cell's state to make it more vulnerable to a targeted therapy. The Eigen platform represents the intersection of biology and engineering, and includes robotic systems, laboratory operations software, and machine learning analysis pipelines—all developed in-house—with the ultimate goal of saving more lives.

Fabric Health

Seed Round in 2023
Fabric Health is a healthcare service provider that operates within laundromats, focusing on enhancing the health and well-being of families. By utilizing the two hours that families spend at laundromats, the company offers access to local healthcare resources and information. This innovative approach allows families to engage with digital health services and improve their overall health experience while attending to their laundry needs.

Dentologie

Venture Round in 2023
Dentologie, founded by Dr. Hany Kurdi in 2013 and headquartered in Chicago, Illinois, aims to transform the dental experience by creating safe and inclusive environments for patients. The company specializes in urban dental solutions, providing a range of tech-enabled services that include general dentistry, Invisalign treatment, oral surgery, and cosmetic dentistry. Dentologie is committed to exceptional customer service and thoughtful design, ensuring that each patient receives personalized care and convenient access to dental solutions. By prioritizing compassion and competence, Dentologie seeks to change the perception of dental visits and enhance overall oral health.

eddii

Seed Round in 2023
Eddii is a health tracking application aimed at individuals living with diabetes, designed to enhance engagement and motivation in managing their health. The application features a virtual character that encourages users to record their daily wellness and adhere to healthy routines through gamification. By providing witty conversations and helpful tips, Eddii aims to make the process of tracking health enjoyable. Users receive weekly reports that highlight their progress, and the app rewards healthy practices and achievements with in-app incentives, fostering a supportive environment for better diabetes management.

VenoStent

Series A in 2023
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.

Ossium Health

Series C in 2023
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

3X Genetics

Pre Seed Round in 2023
3X Genetics specializes in developing medical screening solutions aimed at identifying genetic disorders, particularly in infants and children. The company's technology focuses on screening for conditions such as myotonic dystrophy and other trinucleotide repeat disorders that lead to progressive muscle weakness. By offering these medical technologies, 3X Genetics enables healthcare professionals to proactively identify potential genetic issues, ultimately helping to prevent the birth of children affected by genetic diseases.

PharmaCCX

Seed Round in 2023
PharmaCCX, Inc. is a company that operates a market access platform designed to streamline the pricing and procurement of medicines for healthcare payers, thereby facilitating quicker patient access to necessary treatments. The platform primarily supports oncology pharmaceutical companies and various healthcare systems in the United States and Europe. Founded in 2017 and headquartered in Boston, Massachusetts, PharmaCCX also maintains offices in Stockholm, Sweden; San Mateo, California; and Zug, Switzerland. The company's software enhances the efficiency of market access teams within pharmaceutical companies and payers, enabling them to effectively plan, negotiate, and manage innovative payment models.

Adora Health

Seed Round in 2023
Adora Health is a digital health company focused on supporting women's health during menopause. It has developed a female health application that leverages natural language processing and artificial intelligence to provide personalized advice and resources. The platform offers a range of tools, including telehealth services and lifestyle recommendations, aimed at helping women manage their health, well-being, and nutrition during this transitional phase. By integrating advanced technology with user-friendly features, Adora Health seeks to empower women to take control of their health and improve their quality of life during menopause.

Outbound AI

Seed Round in 2023
Outbound AI is a Seattle-based startup founded in 2021 that specializes in conversational AI tailored for the healthcare sector. The company focuses on automating and streamlining back-office administrative tasks within the revenue cycle, such as claim status checks, eligibility and benefits verification, explanation of benefits capture, and prior authorization processes. By leveraging cloud technologies and a real-time inference engine, Outbound AI enhances productivity and improves the work experience for healthcare professionals. The company's offerings feature AI agents specifically trained to operate within the standard workflows of healthcare roles, promoting greater accuracy and transparency. Outbound AI is supported by a team of experienced professionals from health and voice technology backgrounds, along with backing from prominent venture capital firms.

AlliConnect

Seed Round in 2023
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.

Mend

Series A in 2023
MEND is a life sciences company dedicated to advancing health and recovery through targeted clinical nutrition and medical food interventions. The company focuses on researching and developing products that enhance patient outcomes in various contexts, including injury recovery, surgical recovery, aging, and physical performance. MEND's solutions have been widely adopted by hospitals, health systems, and professional sports teams across major leagues, as well as by the elite forces of the US Military. Through its commitment to ongoing research and development, MEND aims to empower caregivers and improve health outcomes for individuals facing diverse health challenges.

Synteny.Ai

Seed Round in 2023
Synteny.Ai Syntney decodes the signals of immune repertoires to help biotech research and pharma companies with disease discoveries.

DropStat

Venture Round in 2023
DropStat is an app-based software that eliminates the call, text, and wait process of calling staff into open shifts. It also helps hospitals optimize their labor costs by reducing financial waste and improving the patient and staff experience. The company's vision is to bring communication into the 21st century with AI and machine learning, voice technology, and a full suite of tools to eliminate financial waste, increase speed and efficiency, and upgrade staff and patient satisfaction.

Rensair

Series A in 2023
Portable hospital-grade air purifier developed for Scandinavian hospitals, and trusted by businesses globally

Work & Mother

Venture Round in 2023
Work & Mother is a network of fully equipped lactation suites, and a working motherhood support app. The Suites are shared-space commercial building amenities that create an easy way for employers to satisfy legal obligations, enable credits towards WELL/Fitwel/ESG initiatives for building owners, and provide a better solution for working mothers--because the suites have everything a mom needs to pump including hospital-grade equipment, cleaning and sanitizing, refrigeration, and more, and the app provides additional support resources.

Andromeda Surgical

Seed Round in 2023
Andromeda Surgical is a developer of autonomous robots designed to enhance the consistency, accuracy, and efficiency of surgical procedures. The company's open platform focuses on urologic procedures that have demonstrated superior outcomes but face challenges in widespread adoption due to technical complexities. By addressing these difficulties, Andromeda Surgical aims to empower surgeons to perform various procedures at a level typically achieved only by experts, thereby improving patient care and surgical success rates.

mign

Seed Round in 2023
mign is Orthopaedics. Digitally Tailored. mign is reimagining how personalized medical devices for musculoskeletal health are designed, engineered, manufactured, and delivered in a digital and sustainable future.

Jona

Seed Round in 2023
Jona is a technology startup focused on leveraging artificial intelligence to explore the relationship between the microbiome and overall health. The company has developed an advanced microbiome profiling platform that utilizes deep metagenomics technology to analyze a wide range of microorganisms, including bacteria, fungi, viruses, and protists. This analysis creates a comprehensive map that links these microorganisms to various health conditions, symptoms, and food sensitivities. By interpreting microbiome test results, Jona aims to empower individuals to proactively manage their health through informed recommendations on diet, exercise, sleep, and other treatments, addressing the growing prevalence of chronic illnesses.

Options MD

Seed Round in 2023
Options MD is a telemedicine platform focused on delivering personalized care for individuals experiencing severe and treatment-resistant mental illnesses. The platform utilizes artificial intelligence to match patients with innovative depression care options provided by psychiatric experts. By streamlining the referral process to in-house specialists, Options MD enables patients to access appropriate medical care more efficiently, aiming to improve their treatment outcomes.

Womaness

Seed Round in 2023
Womaness is an e-commerce platform that specializes in modern menopause products, aiming to transform the conversation around this natural life stage. The company offers a diverse range of feminine care items designed to address various symptoms associated with menopause, including hot flashes, sleep disturbances, and skin changes. Womaness emphasizes the importance of providing solutions that are free from harmful additives such as parabens, phthalates, sulfates, and hormones, ensuring that its products are vegan and gluten-free. In addition to its product offerings, Womaness fosters a supportive community that shares trusted advice and experiences, empowering women to navigate menopause with confidence and ease.

Dimension Inx

Series A in 2023
Dimension Inx Corp. focuses on designing and developing three-dimensional (3D) printable materials and painted objects for research and commercial applications. The company specializes in creating regenerative microenvironments that aid the body in self-healing. Its biomaterials platform incorporates a complex interplay of material composition, microstructure, and microarchitecture to enhance biofunctionality. Dimension Inx offers a range of products, including Hyperelastic Bone for bone regeneration, 3D printable elastomers, bioactive ceramics, and solutions for soft tissue regeneration. Founded in 2016 and based in Chicago, Illinois, the company aims to provide innovative therapeutic products that restore tissue and organ function, potentially reducing the need for organ transplantation through advanced bio-fabrication processes.

Featureform

Seed Round in 2023
Featureform develops machine learning tools specifically for pharmaceutical and biotechnology companies. The company offers an open-source virtual feature store that enables data scientists to define, manage, and serve machine learning features throughout their organizations. Its platform provides a unified interface to connect, transform, and join both streaming and batch data. Featureform facilitates the discovery and integration of features created by various teams, allowing them to share and enhance their models. Additionally, the platform includes capabilities to monitor and analyze features, as well as to freeze them, which allows teams to concentrate on building models to support their data pipelines effectively.

Gilgamesh Pharmaceuticals

Series B in 2022
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York that specializes in developing novel psychotropic drugs aimed at treating mental illnesses. Established in 2019, the company focuses on creating innovative compounds that enhance the therapeutic benefits of classic psychedelics while improving safety, tolerability, duration, and efficacy. Gilgamesh addresses the growing global mental health crisis by providing treatments for various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Through a combination of medicinal chemistry and drug development expertise, the company aims to accelerate the availability of effective therapies, ultimately improving the quality of life for individuals suffering from central nervous system disorders.

Eigen Therapeutics

Seed Round in 2022
Eigen Therapeutics is a biotechnology company on a mission to make therapies that make cancer easier to find and eliminate. Eigen is focused on the development of “priming” therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthy cells more resilient to treatment. Eigen is building a high-throughput discovery platform to explore the space of priming therapies, leveraging proprietary machine learning algorithms to discover novel associations, new classes of drugs, and new potential therapies that change a cell's state to make it more vulnerable to a targeted therapy. The Eigen platform represents the intersection of biology and engineering, and includes robotic systems, laboratory operations software, and machine learning analysis pipelines—all developed in-house—with the ultimate goal of saving more lives.

Axoft

Seed Round in 2022
Axoft offers a bioinspired, scalable implant that promotes long-term communication with the nervous system, transforming clinical outcomes, individual health, and the human experience.

SURGE Therapeutics

Series A in 2022
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed. The company provides an injectable biodegradable hydrogel that allows for the prolonged, localized release of most cancer immunotherapy on the website of surgical tumor resection by focusing the dose at the right place and right time.

Brave Health

Series C in 2022
Brave Health operates a virtual clinic that provides telehealth services focused on mental health and addiction treatment. Established in 2017 in Miami, Florida, the company specializes in behavioral health, offering a range of services including counseling, therapy, psychiatry, and medication management, which encompasses medication-assisted treatment. This telehealth approach allows patients to receive comprehensive care for various conditions related to mental health and substance use disorders, facilitating greater access to necessary treatment.

PathSpot

Series A in 2022
PathSpot is a company focused on developing contaminant detection devices that identify food-borne pathogens. Its technology employs advanced algorithms to filter, process, and analyze surfaces, cooking utensils, and employees' hands for harmful bacteria. By providing instant detection of invisible pathogens, PathSpot's devices help clients safeguard against foodborne illnesses, ensuring a safer environment in food preparation and handling.

Remedial Health

Seed Round in 2022
Remedial Health operates as a wholesale distributor of medicine, catering to the vast network of approximately one million pharmacies and hospitals across Africa. The company addresses the prevalent inefficiencies in the healthcare supply chain, where providers often depend on open-air markets to acquire pharmaceuticals, leading to risks of counterfeit products. By offering a pharmacy operations and procurement management platform, Remedial Health enhances business-to-business access to medications. This platform incorporates technology that simplifies the ordering process and facilitates direct access to retail medicines from manufacturers or distributors, thereby improving workflow management and ensuring a more reliable supply of genuine medications for healthcare providers.

Fabric Health

Seed Round in 2022
Fabric Health is a healthcare service provider that operates within laundromats, focusing on enhancing the health and well-being of families. By utilizing the two hours that families spend at laundromats, the company offers access to local healthcare resources and information. This innovative approach allows families to engage with digital health services and improve their overall health experience while attending to their laundry needs.

Abingdon Software Group

Seed Round in 2022
Abingdon Software Group specializes in developing critical software solutions for various industries experiencing rapid digital transformation. The company's mission-critical platform serves multiple sectors, including agriculture, shipping, healthcare, logistics, local authorities, resorts, industrial operations, and construction. By providing tailored applications, Abingdon Software Group enables businesses to enhance their essential operations and adapt to the evolving demands of their respective markets.

Health Note

Series A in 2022
Health Note is an AI chatbot platform that streamlines the process of collecting patient information and creating physician notes, thereby enhancing clinic workflows. Founded in 2018 and based in San Francisco, California, the platform allows patients to engage in their own care by providing pre-visit information through a simple SMS link, eliminating the need for app downloads or sign-ins. This frictionless, platform-agnostic solution integrates seamlessly with electronic medical record systems, facilitating the documentation of physician-patient interactions and improving overall healthcare efficiency.

Swing Therapeutics

Series A in 2022
Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.

Sesame

Series B in 2022
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Quadrant Health

Pre Seed Round in 2022
Quadrant Health provides real-time analysis of EHR and patient messaging data to predict patient harm before it occurs. Founded by Krishna Gorrepati and Anin Sayana in 2021, the company has developed a disease prediction platform designed to identify patient infections and injuries earlier and more accurately than other physicians.

Miga

Seed Round in 2022
Miga is a virtual cardiometabolic clinic that combines a character-driven, gamified app (akin to Duolingo) with full-stack clinical services (labs, devices, pharmacy, lifestyle) across obesity, hypertension, diabetes, and hyperlipidemia. Founded by Jarrad Aguirre, MD, and Dre Limberopoulos, Miga is building the future of cardiometabolic health.

NeuraLight

Series A in 2022
NeuraLight is a venture-backed company focused on improving the lives of individuals affected by neurological disorders through digital solutions. The company has developed a digital neurology platform that utilizes a proprietary, de-identified oculometric database. This technology allows for the analysis of eye movement using standard smartphones or webcams, enabling clinicians to effectively differentiate between patients and healthy individuals, categorize various subgroups, and track disease progression. By digitizing evaluation and care, NeuraLight aims to enhance diagnostic accuracy and treatment for those impacted by neurological conditions.

Rensair

Series A in 2022
Portable hospital-grade air purifier developed for Scandinavian hospitals, and trusted by businesses globally

MD Ally

Seed Round in 2022
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.

Health Hero

Seed Round in 2022
Health Hero, Inc. is a wellness platform that focuses on enhancing employee well-being and engagement for organizations worldwide. Founded in 2014 and headquartered in Tampa, Florida, the company provides a range of services, including health risk assessments, cultural assessments, and biometric screenings, accessible through mobile devices and computers. Health Hero's platform is designed to foster a positive workplace environment by integrating gamification elements, allowing employees to earn rewards for achieving wellness milestones. The platform supports over 14,000 companies and communities, reaching more than 5 million users and managing over 5 billion health data points. With a commitment to improving wellness options for employees and their families, Health Hero leverages advanced technology to drive engagement and support sustainable organizational growth.

Concerto Biosciences

Venture Round in 2022
Concerto Biosciences specializes in rebuilding microbial communities to enhance human health and environmental sustainability. The company has developed an ultra-high-throughput platform capable of measuring millions of microbial interactions, enabling the mapping of complex inter-species networks that dictate community behavior. This innovation allows Concerto to create "ensembles," which are specific combinations of microbes that collaboratively promote the recovery of damaged microbial ecosystems. By focusing on these microbial ensembles, Concerto aims to address critical global issues across various sectors, including agriculture, healthcare, and industry. The company's pioneering work positions it as a leader in the development of microbial solutions, fundamentally changing how humanity interacts with microbial life.

Cylera

Convertible Note in 2022
Cylera, Inc. is a cybersecurity company focused on protecting healthcare organizations from cyber threats and malware. Founded in 2017 and headquartered in New York, Cylera offers a comprehensive platform that utilizes patented technology to provide unified cybersecurity solutions. Their software specializes in asset management, risk analysis, and threat detection, specifically designed for the healthcare Internet of Things (IoT) environment. By identifying all connected devices, analyzing vulnerabilities, and mitigating threats in real time, Cylera enables healthcare providers and other organizations to effectively manage risks and respond automatically to potential security incidents.

Legion Health

Seed Round in 2022
Legion Health specializes in telepsychiatry services aimed at improving access to mental health care. The company utilizes technology to facilitate efficient interactions between patients and highly-vetted providers, ensuring that services are covered by insurance. By offering AI-enabled psychiatric care, Legion Health allows healthcare organizations to expand their mental health offerings quickly, connecting patients to the necessary resources while alleviating administrative burdens for clinicians. The focus is on delivering personalized treatment plans and fostering collaboration among care team members to support comprehensive mental wellness.

Heading Health

Seed Round in 2022
Heading Health is a technology-enabled mental health platform focused on enhancing access to affordable mental health care. The platform provides personalized treatment solutions that utilize evidence-based therapeutics and innovative technologies, including Spravato, transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. By offering these services, Heading Health aims to enable patients to experience meaningful improvements in their mental well-being through effective and accessible treatment options.

AlliConnect

Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.

AlliConnect

Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.

Pact

Seed Round in 2022
Pact is a company that specializes in muscle scanning technology aimed at enhancing athletic recovery. It offers a system that analyzes muscle conditions to develop personalized recovery solutions. The company's innovative massager is equipped with a full-feedback app that not only scans muscles but also determines their condition, allowing for tailored warm-up and recovery routines. This adaptive approach to massage treatment is designed to address specific injuries and improve long-term athletic performance. By focusing on individual needs, Pact aims to facilitate faster recovery for athletes.

Hey Jane

Seed Round in 2022
Hey Jane is a telehealth startup that connects patients to healthcare providers that offer online medical consultations. The company's innovative Complete Care model utilizes technology for unparalleled layers of support: medical, emotional, and social. Since 2021, Hey Jane has helped nearly 20,000 patients get the care they need. And this is only the beginning; soon, we will reimagine care for even more common but underserved treatments, with the ultimate goal of becoming the most trusted healthcare company out there—one that pushes the boundaries of access with convenient, inclusive, and patient-driven care.

Verge Genomics

Series B in 2021
Verge Genomics is a biotechnology company focused on transforming drug discovery for neurodegenerative diseases through the application of artificial intelligence. Founded by experts in machine learning and seasoned drug developers in neuroscience, the company aims to leverage advances in computational genomics and insights into brain science to identify promising therapeutic targets. Its drug discovery platform utilizes machine learning algorithms to analyze large datasets, enabling the identification of effective drugs and accelerating the development of life-saving treatments. By improving the efficiency of the drug development process, Verge Genomics seeks to enhance patient outcomes and reduce the overall costs associated with pharmaceutical development.

Droplette

Series B in 2021
Droplette Inc., founded in 2017 and based in Boston, Massachusetts, specializes in the development of a needle-free skincare device that utilizes a patent-pending transdermal delivery system. This innovative technology allows for the delivery of drugs up to 60% larger than traditional treatments, penetrating deeply into the skin over large surface areas. The device is designed to be painless, contact-free, and portable, generating no disposables. Initially aimed at delivering antibiotics for serious skin conditions such as ulcers and infections, Droplette also envisions future applications for localized delivery of chemotherapeutics for skin cancer and anti-aging treatments. By enabling effective skincare without harmful chemicals, Droplette aims to transform skin health through scientific advancement.

Wave Life

Pre Seed Round in 2021
Wave Life is a new kind of mental health platform that makes emotional wellbeing an achievable part of everyday life. The app's mental health coach and toolkit empower users to live each day with intention. Mental health coaching helps to build self-awareness, discover values, and cope with stress.

Transcend Therapeutics

Series A in 2021
Transcend Therapeutics, Inc., established in 1992 in Waltham, Massachusetts, is a clinical-stage company focused on developing pharmaceuticals to address diseases associated with oxidative stress and tissue damage. The company aims to create psychoactive medicines targeting specific brain regions involved in neuropsychiatric disorders. By doing so, Transcend Therapeutics seeks to enable healthcare professionals to facilitate positive changes in brain function and behavior for patients suffering from these conditions.

Outbound AI

Seed Round in 2021
Outbound AI is a Seattle-based startup founded in 2021 that specializes in conversational AI tailored for the healthcare sector. The company focuses on automating and streamlining back-office administrative tasks within the revenue cycle, such as claim status checks, eligibility and benefits verification, explanation of benefits capture, and prior authorization processes. By leveraging cloud technologies and a real-time inference engine, Outbound AI enhances productivity and improves the work experience for healthcare professionals. The company's offerings feature AI agents specifically trained to operate within the standard workflows of healthcare roles, promoting greater accuracy and transparency. Outbound AI is supported by a team of experienced professionals from health and voice technology backgrounds, along with backing from prominent venture capital firms.

Insiteflow

Seed Round in 2021
Insiteflow is a provider of an EHR integrated platform that helps manage clinical decision solutions. The platform helps the practitioner to optimize their clinical workflow solutions by giving POC insights for better decision and treatment planning solutions for patients. It was founded by Anthony Gerardi and Corey Hall in 2018 in Austin, Texas.

Evernow

Convertible Note in 2021
Evernow is a provider of women's health care services focused on supporting women before, during, and after menopause. The company offers an online teleconsultation platform that connects users with specialized doctors and provides access to science-backed information and treatments. Through this platform, Evernow facilitates conversations about effective care for managing changing hormones, empowering women to lead longer and healthier lives.

GritWell

Seed Round in 2021
GritWell Ltd is a digital health platform established in 2018, based in San Francisco, California. The company focuses on addressing chronic health conditions by shifting the emphasis from symptom management to identifying and treating root causes. GritWell connects patients suffering from various chronic symptoms, such as insomnia, migraines, digestive issues, anxiety, and joint pain, with nutritionists, health coaches, and holistic practitioners. Its platform offers personalized care through clinically validated symptom assessments and facilitates secure video consultations, direct messaging, and an online portal for scheduling and managing patient records. By integrating natural treatments and providing tailored treatment plans, GritWell aims to enhance patient outcomes and support a holistic approach to health.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company based in San Francisco, California, founded in 2018. The company focuses on enhancing mental health care for cancer patients through its innovative digital therapeutics platform. By collaborating with medical researchers and patient advocacy organizations, Blue Note Therapeutics delivers evidence-based therapeutic interventions via mobile devices. This approach allows patients to access effective treatments designed to prevent, manage, and address their medical conditions, enabling healthcare providers to utilize these digital solutions as primary or supplementary therapies for serious illnesses.

LingoHealth

Seed Round in 2021
LingoHealth is a digital health platform aimed at assisting family members in supporting the health of their aging loved ones, particularly within multilingual households. By addressing the unique needs of families who speak languages other than English, LingoHealth provides tools that enhance caregiver engagement and improve communication about health care options. The platform empowers family advocates with crucial information to navigate the complexities of care and helps direct their loved ones to the most appropriate health services. This focus on cultural context and language accessibility positions LingoHealth as an essential resource for immigrant families managing the health of elderly relatives.

Kenshō Health

Seed Round in 2021
Kenshō is a health company that lives in LA, operates on the internet, and promotes a whole-person philosophy of care: mind, body, and spirit. The company, founded and led by proven entrepreneurs Krista Berlincourt and Danny Steiner, pairs scientific research with personalization technology to take the guesswork out holistic health, whether you're looking for an honest answer or a trusted provider. Berlincourt is known for nurturing and scaling some of the most loved emerging technology brands like Simple, Acorns, and Microsoft from the ground up. Steiner was a digital innovation change agent at NBC, Conde Nast, and Hulu before breaking into health and wellness with Brami, a venture-backed superfood company.

AdaptX

Series A in 2021
AdaptX is a healthcare data analytics and AI company that specializes in enhancing clinical and workflow outcomes for hospitals and surgery centers. Founded in Seattle in 2016 as a spin-off from Seattle Children's Hospital, AdaptX provides a platform that enables medical leaders and clinicians to access and analyze clinical data effectively. The platform integrates algorithms with existing electronic data systems, allowing healthcare providers to monitor performance, compare treatment approaches, and define patient cohorts. Through automated analytics, AdaptX helps healthcare service providers improve the quality and safety of care while also reducing costs.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.

Asto CT

Series B in 2021
Asto CT LLC specializes in developing advanced X-ray computed tomography (CT) systems aimed at enhancing equine healthcare. Founded in 2015 and based in Madison, Wisconsin, the company focuses on preventing fractures and improving the overall well-being of thoroughbreds, show horses, recreational horses, and older equines. Asto CT's technology enhances fracture risk detection, facilitates the diagnosis of lameness, and aids in the management of dental and sinus conditions. Their flagship product, Equina, delivers rapid 3D imaging of the lower limbs, head, and neck of standing horses without the need for general anesthesia, ensuring a safer and more comfortable experience for the animals. By integrating cutting-edge robotics with fan-beam CT technology, Asto CT is committed to providing high-quality diagnostic imaging that supports veterinarians in delivering effective treatments.

Zone7

Convertible Note in 2021
Zone7 is a technology company founded in 2017 and based in Palo Alto, California, specializing in artificial intelligence-driven sports injury prediction software. The platform leverages data from wearable devices, medical records, and fitness profiles to forecast potential injuries, allowing for proactive measures to enhance athlete safety and performance. Zone7 serves over 30 professional sports franchises, offering insights that enable coaching staff to monitor athlete performance and injury risk effectively. Additionally, the technology is utilized in hospitals to ensure the well-being of medical staff by providing actionable recommendations for optimizing workload and recovery. By analyzing various data sources, Zone7 aims to protect and enhance the health and performance of both athletes and the elite workforce.

CompScience

Seed Round in 2021
CompScience is a technology company that specializes in AI-driven solutions for workers' compensation insurance, emphasizing workplace safety through data analysis and risk identification. The platform aids organizations in evaluating their safety protocols, pinpointing potential hazards, and implementing effective risk management strategies. By utilizing machine learning algorithms, CompScience analyzes historical data to forecast future incidents and suggest preventive measures, ultimately helping businesses lower claims costs and enhance employee safety. Furthermore, the platform fosters communication between safety teams and management, ensuring that safety initiatives align with organizational objectives. It also serves logistics and manufacturing sectors by providing actionable insights, safety monitoring, and a user-friendly dashboard, contributing to measurable reductions in injuries and workers' compensation costs while improving overall performance and employee satisfaction.

miRecule

Venture Round in 2021
miRecule, Inc. is a biotechnology company based in Gaithersburg, Maryland, established in 2016. The company specializes in developing a microRNA-based drug discovery platform, DREAmiR, aimed at addressing challenges in cancer therapy and muscular dystrophy. This innovative platform leverages genomic and outcome data from thousands of patients to identify genetic abnormalities associated with diseases. miRecule formulates RNA therapeutics that can directly target and correct these genetic issues. The platform integrates genomic sequencing, expression, and prognostic data from numerous cancer patients with high throughput screening of microRNA candidates for replacement therapy. miRecule is focused on creating highly tailored therapeutics, with lead programs targeting Head & Neck Cancer and Facioscapulohumeral Muscular Dystrophy, ultimately striving to improve the quality of life for patients suffering from debilitating conditions.

Gilgamesh Pharmaceuticals

Series A in 2021
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York that specializes in developing novel psychotropic drugs aimed at treating mental illnesses. Established in 2019, the company focuses on creating innovative compounds that enhance the therapeutic benefits of classic psychedelics while improving safety, tolerability, duration, and efficacy. Gilgamesh addresses the growing global mental health crisis by providing treatments for various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Through a combination of medicinal chemistry and drug development expertise, the company aims to accelerate the availability of effective therapies, ultimately improving the quality of life for individuals suffering from central nervous system disorders.

Wave Life

Pre Seed Round in 2021
Wave Life is a new kind of mental health platform that makes emotional wellbeing an achievable part of everyday life. The app's mental health coach and toolkit empower users to live each day with intention. Mental health coaching helps to build self-awareness, discover values, and cope with stress.

Insiteflow

Seed Round in 2021
Insiteflow is a provider of an EHR integrated platform that helps manage clinical decision solutions. The platform helps the practitioner to optimize their clinical workflow solutions by giving POC insights for better decision and treatment planning solutions for patients. It was founded by Anthony Gerardi and Corey Hall in 2018 in Austin, Texas.

MD Ally

Seed Round in 2021
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.

Intus Care

Seed Round in 2021
Intus Care, Inc. is a healthcare analytics platform focused on improving patient care and reducing hospitalizations for vulnerable and complex patients. Founded in 2018 and based in North Providence, Rhode Island, the company connects home care providers to patients through an application that tracks provider efficiency via electronic visit verification. Utilizing machine learning, the platform predicts hospital readmissions and identifies patients at high risk for hospitalizations. It also facilitates automatic patient risk grouping, enables care coordination teams to receive notifications about changes in patient health status, and supports the development of data-driven interventions and care plans. By synthesizing financial, clinical, and administrative data, Intus Care helps organizations such as nursing homes, PACE programs, and home care agencies visualize healthcare trends, ultimately aiming to deliver cost-effective healthcare solutions.

Impact Biosystems

Seed Round in 2021
Impact Biosystems develops hardware and software solutions for people in the health and fitness space. They provide hardware-connected recovery platforms that provide users with custom measurements of their bodies and enhance the gamifying and socializing experience.

Bend

Series A in 2021
Bend helps businesses and individuals manage their long-term financial health and the rising expense of healthcare. Their system is made to maximize revenue, ensure that tax savings opportunities are never missed, and facilitate HSA administration and use. They offer a method of participation, funding, saving, and payment by utilizing technology like artificial intelligence and machine learning.

Strategikon Pharma

Series A in 2021
Strategikon Pharma, Inc. specializes in developing software that optimizes the outsourcing processes between sponsors and providers in the pharmaceutical industry. Its flagship product, Clinical Maestro, is a unique platform designed for the comprehensive management of clinical business operations, particularly in planning, outsourcing, and budgeting clinical trials. By facilitating an integrated virtual environment, Clinical Maestro enables biopharmaceutical companies to efficiently manage complex relationships with numerous global service providers who often operate with varying processes and reporting structures. The software replaces traditional, labor-intensive methods—primarily reliant on Excel—leading to significant cost savings and enhanced operational efficiency. Case studies with major pharmaceutical firms highlight the platform's effectiveness, achieving over 80% savings compared to manual processes and over 95% accuracy in predicting clinical study budgets. Founded in 2016 and headquartered in San Rafael, California, Strategikon Pharma also offers consulting services to support new clinical business operations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.